Cancer Immunotherapy in India: Advanced Care for 80% Less
Introduction
The 2018 Nobel Prize in Medicine established Immunotherapy as the fourth pillar of cancer care (alongside surgery, chemo, and radiation). It harnesses your own immune system to fight cancer.
The challenge? Cost. In the US, checkpoint inhibitors (like Keytruda or Opdivo) can cost $150,000+ per year. India offers the exact same FDA-approved drugs and cutting-edge therapies like CAR-T Cell Therapy at a fraction of the price.
Cost Breakdown
| Therapy | USA Cost (Annual) | India Cost (Annual) |
|---|---|---|
| Checkpoint Inhibitors | $150,000+ | $20,000 - $35,000 |
| CAR-T Cell Therapy | $400,000+ | $40,000 - $60,000 |
| CyberKnife Radiosurgery | $60,000+ | $6,000 - $8,000 |
World-Class Bio-similars
India is the "Pharmacy of the World". Many FDA-approved bio-similars for immunotherapy drugs are manufactured here, drastically reducing the cost while maintaining 100% efficacy.
Success Stories
From Stage 4 Melanoma to Lung Cancer remission, Indian oncologists at Tata Memorial and Apollo are leading global clinical trials, ensuring you get the latest science-backed treatments.
Conclusion
A cancer diagnosis is overwhelming. Paying for it shouldn't be. Access top-tier Immunotherapy and genomic medicine in India without bankrupting your family.
Tags
Talk to Dr. Maya About This
Ready to explore Oncology options? Dr. Maya can answer your questions and help you take the next step.
Popular questions:
Prefer to speak with a human? Our care coordinators are here to help.